Now Available: Turkey Pharmaceuticals & Healthcare Report Q2 2013
The Turkish pharmaceutical market contracted significantly in 2012, in line with our previous forecasts. We continue to hold a positive long-term view on the market's potential, owing to Turkey's rapid economic growth and rising per capita spending. However, state intervention in the pharmaceutical sector continues to stifle the industry's potential and restrict foreign drugmakers' access to the country's lucrative market.
View full press release